Vimarsana
Biggest News Aggregation in the World

Ocast Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ocast Report. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ocast Report Today - Breaking & Trending Today

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo - Vimarsana News

Roche receives FDA approval of label expansion for VENTANA PD-L1 (SP263) Assay to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

/PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the VENTANA PD-L1 (SP263)...

Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo - Vimarsana News

Roche's VENTANA PD-L1 (SP263) Assay receives CE IVD approval to identify patients with locally advanced and metastatic non-small cell lung cancer eligible for Libtayo

The VENTANA PD-L1 (SP263) Assay helps determine which patients with non-small cell lung cancer may be eligible for treatment with Libtayo monotherapy1 based on...

TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting - Vimarsana News

TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Triton Digital Releases November 2021 U.S. Podcast Report, Stitcher Media Leads - Vimarsana News

Triton Digital Releases November 2021 U.S. Podcast Report, Stitcher Media Leads

TRITON DIGITAL has released the latest U.S. POCAST REPORT for the NOVEMBER 2021 reporting period as measured by its PODCAST METRICS measurement service.STITCHER MEDIA remained in the #1 spot on the TOP NETWORKS REPORT with 40.3m Average Weekly Downloads and 11.1m Average Weekly Users, followed by, NPR with 31.1m Average Weekly Downloads and 6.8m Average Weekly Users, and AUDACY PODCAST NETWORK with 30.9m Average Weekly Downloads and 9.1m Average Weekly Users.The top three podcasts include NPR ...

IMFINZI Demonstrated Unprecedented Survival in Unresectable Stage III Lung Cancer With 43% Of Patients Surviving Five Years - Vimarsana News

IMFINZI Demonstrated Unprecedented Survival in Unresectable Stage III Lung Cancer With 43% Of Patients Surviving Five Years

Long-term data from PACIFIC Phase III trial at ASCO showed 33% of patients remained progression-free at five years Longest-ever survival reported in a Phase III immunotherapy trial in this setting ...